Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
VA Connecticut Healthcare System
The current proposal aims to study the pharmacotherapeutic effects of intranasal insulin on PTSD symptoms and inhibition of amygdala hyperactivation in subjects with PTSD.
Age
21–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 21-65 years old
Current PTSD
Able to provide written informed consent
You may not be if
Unstable medical condition, clinically determined by a physician
Diabetes requiring insulin or oral hypoglycemic agents
Moderate-severe traumatic brain injury
Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months
Changes in doses of psychotropic medications in the past 4 weeks
Initiation of individual therapy or counseling in the past 4 weeks
Imminent suicidal or homicidal risk
Contraindication to Insulin
History of claustrophobia
Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire
Clareo Health | Intranasal Insulin for Posttraumatic Stress Disorder
